Post-Approval, Real-Time Monitoring Will Help Approval Standards, US FDA’s Makary Says

 
• By Sue Sutter
FDA Commissioner Martin Makary and other international regulators, scientists and a patient spoke during the DIA Global Annual Meeting's opening plenary. (Sue Sutter)

More from Real-World Evidence

More from Pink Sheet